JiangLTangKLevinM, et al.COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis2020; 20: E276–E288.
2.
AhmedMAdvaniSMoreiraA, et al.Multisystem inflammatory syndrome in children: a systematic review. EClinicalMedicine2020; 26: 100527–100527.
3.
MatsubaraDKauffmanHLWangY, et al.Echocardiographic findings in pediatric multisystem inflammatory syndrome associated with COVID-19 in the United States. J Am Coll Cardiol2020; 76: 1947–1961.
4.
RamcharanTNolanOLaiCY, et al.Paediatric inflammatory multisystem syndrome: temporally associated with SARS-CoV-2 (PIMS-TS): cardiac features, management and short-term outcomes at a UK tertiary paediatric hospital. Pediatr Cardiol2020; 41: 1391–1401.
5.
SperottoFFriedmanKGSonMBF, et al.Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach. Eur J Pediatr2020; 15: 1–16.
6.
EWhittakerABamfordJKenny. PIMS-TS Study Group and EUCLIDS and PERFORM Consortia. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA2020; 21: 259–269.
7.
HendersonLACannaSWFriedmanKG, et al.American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 1. Arthritis Rheumatol2020; 72: 1791–1805.
8.
McCrindleBWRowleyAHNewburgerJW, et al.American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals from the American Heart Association. Circulation2017; 135: e927–e999.
